Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05752110
Other study ID # 106/2022
Secondary ID
Status Completed
Phase Phase 4
First received
Last updated
Start date April 1, 2022
Est. completion date September 1, 2022

Study information

Verified date November 2023
Source Istanbul Training and Research Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

When given intravenously in doses below 1.2mg/kg, ketamine has been shown to work as an antidepressant. Ketamine is a common induction drug used during general anesthesia. It is known to reduce postoperative pain in this instance. Limited studies have evaluated the effect of a single subanesthetic dosage of ketamine administered as an adjunct to general anesthesia on acute mood states in patients undergoing minor surgery. The aim of this randomized controlled study was to examine if a single intravenous administration of 0.5 mg/kg ketamine given at the induction of propofol/fentanyl anesthesia has an effect on acute mood states before the discharge of women undergoing fractional curettage.


Description:

Women admitted for fractional curettage between the ages of 18 and 75 were asked if they would like to participate in the study. Exclusion criteria included uncontrolled hypertension, pregnancy, history of psychologic disorders, use of brain-affecting medicines, substance abuse, seizure disorders, or ketamine allergy. After receiving informed consent, the patient would be given a POMS questionnaire. The participants were then assigned randomly to one of two groups. Group A will receive ketamine intravenously at a dose of 0.5 mg/kg as part of the induction process for general anesthesia. In addition to their anesthetic, Group B will get the same amount of saline instead of ketamine. Patients were treated by a different anesthetic professional (who is blinded to the group the patient is in). All other induction medicines were administered at the discretion of the anesthesiologist. Two hours after the surgery, participants were again administered the POMS questionnaire, questioned about their pain level, and their data sheet was updated accordingly. During the trial, the levels of sedation, systolic and diastolic blood pressures and heart rate were measured. In addition, any adverse events were documented.


Recruitment information / eligibility

Status Completed
Enrollment 140
Est. completion date September 1, 2022
Est. primary completion date September 1, 2022
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria: - consecutive patients (>18 years) undergoing fractional curettage Exclusion Criteria: - American Society of Anesthesiologists' physical status = 3 - History of psychological disorders - Use of drugs affect central nervous system - Substance abuse - Chronic pain - Pregnancy - Seizure disorders - Cardiovascular, hepatic or renal disease

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Ketamine
0,5mg/kg single dose Ketamine (0.05ml/kg) intravenously administered
Other:
Saline
0.09% Saline (0.05ml/kg) intravenously administered

Locations

Country Name City State
Turkey Istanbul Training and Research Hospital Istanbul Fatih
Turkey IstanbulTRH Istanbul

Sponsors (1)

Lead Sponsor Collaborator
Istanbul Training and Research Hospital

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Comparing total mood scores of both groups using Profile of Mood States (POMS) Questionnaire. The Turkish version of Profile of Mood States (POMS) is an validated instrument that measures mood using a 58-item questionnaire with each item rated using a response scale of five categories ranging from "not at all" to "very strong". Higher score indicates worse mood.As a global measure of affective state, a total mood score (TMS) is calculated by combining the negative mood subscore (NMS) totals (fatigue-inertia, anger-hostility, confusion-bewilderment, depression-dejection, tension-anxiety,) and subtracting the positive mood subscore (PMS) (vigor-activity). The minimum value of TMS is -24, the maximum value is+177. Total Mood Score measured 120 minutes after surgery
Primary Impact of clinical variables on total mood scores using Profile of Mood States (POMS) We perform multiple linear regression analyses to examine the independent predictors of changes in postoperative TMS in the entire study group, patients in group-K and group-C, separately. Postoperative TMS is the dependent variable; menopausal status, parity, educational level, body mass index (BMI) and preoperative TMS are independent variables. 120 minutes after surgery
Secondary Numeric rating scale for pain assessment Numeric rating scale score (NRS) is commonly used for measuring pain intensity. It is scored from 0-10; 0 means no pain and 10 is the worst pain imaginable. NRS assessed at the 120 minutes postoperatively 120 minutes after surgery
Secondary Systolic blood pressure Measuring systolic blood pressure (mmHg) before surgery and 120 minutes after surgery and comparing values between and within group K and group C immediately before surgery and 120 minutes after surgery
Secondary diastolic blood pressure Measuring diastolic blood pressure (mmHg) before surgery and 120 minutes after surgery and comparing values within groups and comparing values between and within group K and group C immediately before surgery and 120 minutes after surgery
Secondary heart rate Measuring number of heart beats per minute before surgery and 120 minutes after surgery and comparing values within groups and comparing values between and within group K and group C immediately before surgery and 120 minutes after surgery
Secondary The Michigan Sedation Score assessment Comparing depth of sedations of two groups using the University of Michigan Sedation Scale (UMSS). This sedation scale ranges from zero to four with higher numbers indicating deeper sedation. immediately Before surgery, 60 minutes after surgery and 120 minutes after surgery
Secondary Diplopia Presence of absence of diplopia reported in clinical records electronic database by nurse or physician within time frame 120 minutes after surgery
Secondary Headache Presence of absence of headache reported in clinical records electronic database by nurse or physician within time frame 120 minutes after surgery
Secondary Psychedelic phenomena Presence of absence of psychedelic phenomena reported in clinical records electronic database by nurse or physician within time frame 120 minutes after surgery
Secondary Nausea Presence of absence of nausea reported in clinical records electronic database by nurse or physician within time frame 120 minutes after surgery
Secondary Vomiting Presence of absence of vomiting reported in clinical records electronic database by nurse or physician within time frame 120 minutes after surgery
Secondary Patient satisfaction Evaluation of patient satisfaction 120 minutes after surgery. Satisfaction is rated on a scale of 1 to 4 (1 perfect, 2 good, 3 moderate, and 4 bad). 120 minutes after surgery
Secondary Physician satisfaction Evaluation of physician satisfaction 120 minutes after surgery. Satisfaction is rated on a scale of 1 to 4 (1 perfect, 2 good, 3 moderate, and 4 bad). 120 minutes after surgery
See also
  Status Clinical Trial Phase
Terminated NCT03781817 - Intranasal Versus Intravenous Ketamine for Procedural Sedation in Children With Non-operative Fractures Phase 4
Completed NCT04199468 - THC and Ketamine Effects in Humans: Relation to Neural Oscillations and Psychosis Phase 1
Recruiting NCT03272698 - ECT With Ketamine Anesthesia vs High Intensity Ketamine With ECT Rescue for Treatment-Resistant Depression Phase 4
Completed NCT02987985 - Efficacy of Opioid-free Anesthesia in Reducing Postoperative Respiratory Depression in Children Undergoing Tonsillectomy Phase 3
Recruiting NCT05089526 - Opioid-free Anesthesia in Laparoscopic Cholecystectomies N/A
Completed NCT06243822 - Ketamine Versus Propofol as ICU Sedation Phase 4
Completed NCT04022226 - EEG Characteristics in ECT Early Phase 1
Completed NCT03336541 - Low-dose Ketamine and Postpartum Depression in Parturients With Prenatal Depression Phase 4
Recruiting NCT04622904 - Lidocaine and Magnesium and Ketamine in Gynecological Surgery N/A
Recruiting NCT05717361 - Opioid Sparing Anesthesia in Cervical Spine Surgery N/A
Completed NCT03375671 - Rapid Agitation Control With Ketamine in the Emergency Department Phase 2
Recruiting NCT02717052 - Positron Emission Tomography Assessment of Ketamine Binding of the Serotonin Transporter Phase 2
Recruiting NCT05837000 - Dexmedetomidine, Ketamine and Magnesium Sulphate in Caudal Block for Hypospadias Repair Phase 4
Recruiting NCT04144933 - Effect of Multimodal Opioid-free Anesthesia on Return of Bowel Function in Laparoscopic Colorectal Surgery Phase 3
Recruiting NCT06431178 - General Anesthesia Versus Sedation By Dexmedetomidine and Ketamine With Local Infiltration for Percutaneous Transcatheter Closure of Atrial Septal Defect in Pediatric Patients N/A
Recruiting NCT05243940 - Opioid-free Anesthesia in Thyroidectomies N/A
Completed NCT05288764 - Effect of Ketamine on BIS Values
Recruiting NCT06331182 - Dexmedetomidine and Ketamine as an Adjuvant in External Oblique Intercostal Plane Block for Post Thoracotomy Pain N/A
Completed NCT03231683 - Use of S+Ketamine During Target-Controlled Intravenous Anaesthesia After Abdominal Hysterectomy Phase 2
Recruiting NCT05256264 - Machine-learning Algorithm to Differentiate Intraoperative Ketamine Dosing Based on Electroencephalographic Density Spectrum Array Analysis